Emerging role of precision medicine in biliary tract cancers

28Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Biliary tracts cancers (BTCs) are a diverse group of aggressive malignancies with an overall poor prognosis. Genomic characterization has uncovered many putative clinically actionable aberrations that can also facilitate the prognostication of patients. As such, comprehensive genomic profiling is playing a growing role in the clinical management of BTCs. Currently however, there is only one precision medicine approved by the US Food and Drug Administration (FDA) for the treatment of BTCs. Herein, we highlight the prevalence and prognostic, diagnostic, and predictive significance of recurrent mutations and other genomic aberrations with current clinical implications or emerging relevance to clinical practice. Some ongoing clinical trials, as well as future areas of exploration for precision oncology in BTCs are highlighted.

References Powered by Scopus

A microRNA expression signature of human solid tumors defines cancer gene targets

5185Citations
N/AReaders
Get full text

Comprehensive molecular characterization of gastric adenocarcinoma

4977Citations
N/AReaders
Get full text

Genome-scale CRISPR-Cas9 knockout screening in human cells

3831Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Circulating tumor DNA in biliary tract cancer: Current evidence and future perspectives

84Citations
N/AReaders
Get full text

Progress in refining the clinical management of cancer of unknown primary in the molecular era

77Citations
N/AReaders
Get full text

Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers

47Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bogenberger, J. M., DeLeon, T. T., Arora, M., Ahn, D. H., & Borad, M. J. (2018, December 1). Emerging role of precision medicine in biliary tract cancers. Npj Precision Oncology. Nature Publishing Group. https://doi.org/10.1038/s41698-018-0064-z

Readers over time

‘18‘19‘20‘21‘22‘24036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

59%

Researcher 6

35%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 16

73%

Agricultural and Biological Sciences 3

14%

Biochemistry, Genetics and Molecular Bi... 2

9%

Social Sciences 1

5%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 17

Save time finding and organizing research with Mendeley

Sign up for free
0